Align Technology, Inc. (ALGN)

Align Technology's stock price experienced a significant decline of 48.19% between September 24, 2024, and September 23, 2025. In Q1 2023, Align Technology's board authorized a $1.0 billion Stock Repurchase Program. On September 23, 2025, Align Technology filed a complaint with the U.S. International Trade Commission (ITC) to block unlawful imports of clear aligners from its Chinese rival, Angelalign Technology, and also launched patent infringement lawsuits in the U.S., Europe, and China weeks prior.

Align Technology's products and services experience demand seasonality. There has been noted pronounced softness due to summer seasonality in EMEA and North America, particularly affecting Invisalign adult cases. Conversely, Invisalign Teen cases have shown significant boosts, driven by strong demand in markets like China.

Align Technology, Inc. (ALGN) is a global medical device company specializing in orthodontics, restorative, and aesthetic dentistry products, operating primarily in the Health Care sector. Its major products include the Invisalign system of clear aligners, iTero intraoral scanners, exocad CAD/CAM software, Vivera retainers, OrthoCAD digital services, and ClinCheck software.

Align Technology's corporate headquarters are located in Tempe, Arizona, U.S. The company has a significant global presence with operational facilities and offices in the United States, Costa Rica, Poland, Israel, Switzerland (Zug), Mexico (Juarez), and China (Ziyang, Chengdu). It also operates subsidiaries in Hong Kong, Australia, Brazil (São Paulo), and Singapore, selling Invisalign in these markets.

In the past year, Align Technology's brand reputation has been impacted by both positive recognition and past criticisms. The company received top-tier recognition in Institutional Investor's 2022 Most Honored Companies Awards. However, Align Technology faced criticism during and after the 2022 Russian invasion of Ukraine for its decision to remain in the Russian market.

Align Technology (NASDAQ: ALGN) is predominantly owned by institutional shareholders, who hold 92.24% of the company's shares. Insiders own 16.11%, while retail investors hold 0.00%. Major institutional owners include Vanguard Group Inc., BlackRock, Inc., and State Street Corp. The largest individual shareholder is Joseph Lacob, who owns 3.84 million shares, representing 5.29% of the company.